KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Sarepta Therapeutics (SRPT) over the last 15 years, with Q3 2025 value amounting to $192.3 million.

  • Sarepta Therapeutics' Prepaid Assets rose 1623.91% to $192.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $192.3 million, marking a year-over-year increase of 1623.91%. This contributed to the annual value of $90.5 million for FY2024, which is 1640.25% up from last year.
  • According to the latest figures from Q3 2025, Sarepta Therapeutics' Prepaid Assets is $192.3 million, which was up 1623.91% from $127.6 million recorded in Q2 2025.
  • Sarepta Therapeutics' Prepaid Assets' 5-year high stood at $192.3 million during Q3 2025, with a 5-year trough of $74.7 million in Q2 2024.
  • Its 5-year average for Prepaid Assets is $134.9 million, with a median of $141.7 million in 2021.
  • Per our database at Business Quant, Sarepta Therapeutics' Prepaid Assets surged by 8198.18% in 2021 and then tumbled by 5384.91% in 2024.
  • Quarter analysis of 5 years shows Sarepta Therapeutics' Prepaid Assets stood at $149.0 million in 2021, then rose by 0.58% to $149.9 million in 2022, then crashed by 48.15% to $77.7 million in 2023, then grew by 16.4% to $90.5 million in 2024, then soared by 112.63% to $192.3 million in 2025.
  • Its last three reported values are $192.3 million in Q3 2025, $127.6 million for Q2 2025, and $105.5 million during Q1 2025.